161
Views
3
CrossRef citations to date
0
Altmetric
Perspectives

Using Telemedicine to Assess and Manage Psychosis Among Outpatients with Neurodegenerative Disease

ORCID Icon, , , , , & show all
Pages 10271-10280 | Published online: 23 Dec 2021

References

  • Plassman BL, Langa KM, Fisher GG, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29(1–2):125–132. doi:10.1159/000109998
  • Goodman RA, Lochner KA, Thambisetty M, Wingo TS, Posner SF, Ling SM. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011–2013. Alzheimers Dement. 2017;13(1):28–37. doi:10.1016/j.jalz.2016.04.002
  • Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology. 2013;80(19):1778–1783. doi:10.1212/WNL.0b013e31828726f5
  • Yang W, Hamilton JL, Kopil C, et al. Current and projected future economic burden of Parkinson’s disease in the U.S. NPJ Parkinsons Dis. 2020;6(1):15. doi:10.1038/s41531-020-0117-1
  • Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol. 2010;67(8):996–1001. doi:10.1001/archneurol.2010.166
  • Connors MH, Ames D, Woodward M, Brodaty H. Psychosis and clinical outcomes in Alzheimer disease: a longitudinal study. Am J Geriatr Psychiatry. 2018;26(3):304–313. doi:10.1016/j.jagp.2017.10.011
  • Scarmeas N, Brandt J, Albert M, et al. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol. 2005;62(10):1601–1608. doi:10.1001/archneur.62.10.1601
  • Russ TC, Batty GD, Starr JM. Cognitive and behavioural predictors of survival in Alzheimer disease: results from a sample of treated patients in a tertiary-referral memory clinic. Int J Geriatr Psychiatry. 2012;27(8):844–853. doi:10.1002/gps.2795
  • Peters ME, Schwartz S, Han D, et al. Neuropsychiatric symptoms as predictors of progression to severe Alzheimer’s dementia and death: the Cache County Dementia progression study. Am J Psychiatry. 2015;172(5):460–465. doi:10.1176/appi.ajp.2014.14040480
  • Choi A, Ballard C, Martyr A, et al. The impact of auditory hallucinations on “living well” with dementia: findings from the IDEAL programme. Int J Geriatr Psychiatry. 2021;36(9):1370–1377. doi:10.1002/gps.5533
  • Goetz CG, Fan W, Leurgans S. Antipsychotic medication treatment for mild hallucinations in Parkinson’s disease: positive impact on long-term worsening. Mov Disord. 2008;23(11):1541–1545. doi:10.1002/mds.22132
  • Czeisler ME, Marynak K, Clarke KEN, et al. Delay or avoidance of medical care because of COVID-19-related concerns - United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(36):1250–1257. doi:10.15585/mmwr.mm6936a4
  • World Health Organization. The impact of the COVID-19 pandemic on noncommunicable disease resources and services: results of a rapid assessment; 2020. Available from: https://www.who.int/publications/i/item/ncds-covid-rapid-assessment. Accessed April 21, 2021.
  • Mehrotra A, Chernew ME, Linetsky D, Hatch H, Cutler D, Schneider EC. The impact of COVID-19 on outpatient visits in 2020: visits remained stable, despite a late surge in cases; 2021. Available from: https://www.commonwealthfund.org/publications/2021/feb/impact-covid-19-outpatient-visits-2020-visits-stable-despite-late-surge. Accessed December 6, 2021.
  • Centers for Medicare & Medicaid Services. Medicare telemedicine health care provider fact sheet; 2020. Available from: https://www.cms.gov/newsroom/fact-sheets/medicare-telemedicine-health-care-provider-fact-sheet. Accessed April 21, 2021.
  • Fasano A, Antonini A, Katzenschlager R, et al. Management of advanced therapies in Parkinson’s disease patients in times of humanitarian crisis: the COVID-19 experience. Mov Disord Clin Pract. 2020;7(4):361–372. doi:10.1002/mdc3.12965
  • Koonin LM, Hoots B, Tsang CA, et al. Trends in the use of telehealth during the emergence of the COVID-19 pandemic - United States, January-March 2020. MMWR Morb Mortal Wkly Rep. 2020;69(43):1595–1599. doi:10.15585/mmwr.mm6943a3
  • Patel SY, Mehrotra A, Huskamp HA, Uscher-Pines L, Ganguli I, Barnett ML. Trends in outpatient care delivery and telemedicine during the COVID-19 pandemic in the US. JAMA Intern Med. 2021;181(3):388–391. doi:10.1001/jamainternmed.2020.5928
  • Shore JY, Yellowlees P. The COVID-19 pandemic and virtual care: the transformation of psychiatry. Psychiatr News. 2021;56(5):19–34. doi:10.1176/appi.pn.2021.5.30
  • Moran M. After the pandemic: What Will the ‘New Normal’ be in psychiatry? Psychiatr News. 2021;56(5):1.
  • Barton C, Morris R, Rothlind J, Yaffe K. Video-telemedicine in a memory disorders clinic: evaluation and management of rural elders with cognitive impairment. Telemed J E-Health. 2011;17(10):789–793. doi:10.1089/tmj.2011.0083
  • Azad N, Amos S, Milne K, Power B. Telemedicine in a rural memory disorder clinic-remote management of patients with dementia. Can Geriatr J. 2012;15(4):96–100. doi:10.5770/cgj.15.28
  • Martin-Khan M, Flicker L, Wootton R, et al. The diagnostic accuracy of telegeriatrics for the diagnosis of dementia via video conferencing. J Am Med Dir Assoc. 2012;13(5):487 e419–424. doi:10.1016/j.jamda.2012.03.004
  • Hunter MB, Jenkins N, Dolan C, Pullen H, Ritchie C, Muniz-Terrera G. Reliability of telephone and videoconference methods of cognitive assessment in older adults with and without dementia. J Alzheimers Dis. 2021;81(4):1625–1647. doi:10.3233/JAD-210088
  • Carotenuto A, Traini E, Fasanaro AM, Battineni G, Amenta F. Tele-neuropsychological assessment of Alzheimer’s disease. J Pers Med. 2021;11(8):688. doi:10.3390/jpm11080688
  • Myers TL, Tarolli CG, Adams JL, et al. Video-based Parkinson’s disease assessments in a nationwide cohort of Fox insight participants. Clin Park Relat Disord. 2021;4:100094. doi:10.1016/j.prdoa.2021.100094
  • Beck CA, Beran DB, Biglan KM, et al. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017;89(11):1152–1161. doi:10.1212/WNL.0000000000004357
  • Yi JS, Pittman C, Price CL, Nieman CL, Oh ES. Telemedicine and dementia care: a systematic review of barriers and facilitators. J Am Med Dir Assoc. 2021;22(7):1396–1402.e18. doi:10.1016/j.jamda.2021.03.015
  • Sharp IR, Kobak KA, Osman DA. The use of videoconferencing with patients with psychosis: a review of the literature. Ann Gen Psychiatry. 2011;10(1):14. doi:10.1186/1744-859X-10-14
  • Shen J, Kobak KA, Zhao Y, Alexander MM, Kane JM. Use of remote centralized raters via live 2-way video in a multicenter clinical trial for schizophrenia. J Clin Psychopharmacol. 2008;28(6):691–693. doi:10.1097/JCP.0b013e31818c9ba3
  • Pandina GJ, Lindenmayer JP, Lull J, et al. A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia. J Clin Psychopharmacol. 2010;30(3):235–244. doi:10.1097/JCP.0b013e3181dd3103
  • International Parkinson and Movement Disorder Society. International Parkinson and movement disorder society steps for conducting a telemedicine visit; 2020. Available from: https://www.movementdisorders.org/MDS/About/Committees–Other-Groups/Telemedicine-in-Your-Movement-Disorders-Practice-A-Step-by-Step-Guide/Step-5.htm. Accessed April 29, 2021.
  • American Psychiatric Association. Telepsychiatry toolkit; 2021. Available from: https://www.psychiatry.org/psychiatrists/practice/telepsychiatry/toolkit. Accessed June 8, 2021.
  • American Medical Association. Telehealth implementation playbook; 2020. Available from: https://www.ama-assn.org/system/files/2020-04/ama-telehealth-playbook.pdf. Accessed April 21, 2021.
  • American Academy of Family Physicians. A toolkit for building and growing a sustainable telehealth program in your practice; 2020. Available from: https://www.aafp.org/dam/AAFP/documents/practice_management/telehealth/2020-AAFP-Telehealth-Toolkit.pdf. Accessed April 21, 2021.
  • Batsis JA, DiMilia PR, Seo LM, et al. Effectiveness of ambulatory telemedicine care in older adults: a systematic review. J Am Geriatr Soc. 2019;67(8):1737–1749. doi:10.1111/jgs.15959
  • Wilkinson JR, Spindler M, Wood SM, et al. High patient satisfaction with telehealth in Parkinson disease: a randomized controlled study. Neurol Clin Pract. 2016;6(3):241–251. doi:10.1212/CPJ.0000000000000252
  • Adams JL, Myers TL, Waddell EM, Spear KL, Schneider RB. Telemedicine: a valuable tool in neurodegenerative diseases. Curr Geriatr Rep. 2020;9(2):72–81. doi:10.1007/s13670-020-00311-z
  • Uc EY, Rizzo M, O’Shea AMJ, Anderson SW, Dawson JD. Longitudinal decline of driving safety in Parkinson disease. Neurology. 2017;89(19):1951–1958. doi:10.1212/WNL.0000000000004629
  • Deeb W, Hess CW, Gamez N, Patel B, Moore K, Armstrong MJ. Response to telemedicine visits from patients with Parkinsonism during the COVID-19 pandemic on postvisit surveys. J Patient Exp. 2021;8:2374373521997224. doi:10.1177/2374373521997224
  • Leff B, Carlson CM, Saliba D, Ritchie C. The invisible homebound: setting quality-of-care standards for home-based primary and palliative care. Health Aff. 2015;34(1):21–29. doi:10.1377/hlthaff.2014.1008
  • Musich S, Wang SS, Hawkins K, Yeh CS. Homebound older adults: prevalence, characteristics, health care utilization and quality of care. Geriatr Nurs. 2015;36(6):445–450. doi:10.1016/j.gerinurse.2015.06.013
  • Dorsey ER, George BP, Leff B, Willis AW. The coming crisis: obtaining care for the growing burden of neurodegenerative conditions. Neurology. 2013;80(21):1989–1996. doi:10.1212/WNL.0b013e318293e2ce
  • Lam K, Lu AD, Shi Y, Covinsky KE. Assessing telemedicine unreadiness among older adults in the United States during the COVID-19 pandemic. JAMA Intern Med. 2020;180(10):1389–1391. doi:10.1001/jamainternmed.2020.2671
  • Swarztrauber K, Vickrey BG. Do neurologists and primary care physicians agree on the extent of specialty involvement of patients referred to neurologists? J Gen Intern Med. 2004;19(6):654–661. doi:10.1111/j.1525-1497.2004.30535.x
  • Lin S, Sattler A, Smith M. Retooling primary care in the COVID-19 era. Mayo Clin Proc. 2020;95(9):1831–1834. doi:10.1016/j.mayocp.2020.06.050
  • Possin KL, Merrilees JJ, Dulaney S, et al. Effect of collaborative dementia care via telephone and internet on quality of life, caregiver well-being, and health care use: the care ecosystem randomized clinical trial. JAMA Intern Med. 2019;179(12):1658. doi:10.1001/jamainternmed.2019.4101
  • Shore JH, Yellowlees P, Caudill R, et al. Best practices in videoconferencing-based telemental health April 2018. Telemed J E-Health. 2018;24(11):827–832. doi:10.1089/tmj.2018.0237
  • American Hospital Association. Detailed summary of health provisions in consolidated appropriations act, 2021; 2021. Available from: https://www.aha.org/system/files/media/file/2020/12/detailed-summary-health-provisions-consolidated-appropriations-act-2021-bulletin-12-22-20.pdf. Accessed April 21, 2021.
  • Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry. 2006;14(3):191–210. doi:10.1097/01.JGP.0000200589.01396.6d
  • Jeste DV. Tardive dyskinesia in older patients. J Clin Psychiatry. 2000;61(Suppl 4):27–32.
  • Cornett EM, Novitch M, Kaye AD, Kata V, Kaye AM. Medication-Induced Tardive Dyskinesia: a review and update. Ochsner J. 2017;17(2):162–174.
  • Keepers GA, Fochtmann LJ, Anzia JM, et al. The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry. 2020;177(9):868–872. doi:10.1176/appi.ajp.2020.177901
  • Eisenberg JL, Hou JG, Barbour PJ. Current perspectives on the role of telemedicine in the management of Parkinson’s disease. Smart Homecare Technol Telehealth. 2018;5:1–12. doi:10.2147/SHTT.S152018
  • Gire N, Farooq S, Naeem F, et al. mHealth based interventions for the assessment and treatment of psychotic disorders: a systematic review. Mhealth. 2017;3:33. doi:10.21037/mhealth.2017.07.03
  • Dorsey ER, Venkataraman V, Grana MJ, et al. Randomized controlled clinical trial of “virtual house calls” for Parkinson disease. JAMA Neurol. 2013;70(5):565–570. doi:10.1001/jamaneurol.2013.123
  • Drerup B, Espenschied J, Wiedemer J, Hamilton L. Reduced no-show rates and sustained patient satisfaction of telehealth during the COVID-19 pandemic. Telemed J E-Health. 2021;25(1):40–44. doi:10.1089/tmj.2021.0002
  • Mammen JR, Elson MJ, Java JJ, et al. Patient and physician perceptions of virtual visits for Parkinson’s disease: a qualitative study. Telemed J E-Health. 2018;24(4):255–267. doi:10.1089/tmj.2017.0119
  • Spear KL, Auinger P, Simone R, Dorsey ER, Francis J. Patient views on telemedicine for Parkinson disease. J Parkinsons Dis. 2019;9(2):401–404. doi:10.3233/JPD-181557
  • Qiang JK, Marras C. Telemedicine in Parkinson’s disease: a patient perspective at a tertiary care centre. Parkinsonism Relat Disord. 2015;21(5):525–528. doi:10.1016/j.parkreldis.2015.02.018
  • Venkataraman V, Donohue SJ, Biglan KM, Wicks P, Dorsey ER. Virtual visits for Parkinson disease: a case series. Neurol Clin Pract. 2014;4(2):146–152. doi:10.1212/01.CPJ.0000437937.63347.5a